Arbutus Biopharma (ABUS) PT Lowered to $7 at JMP Securities
Tweet
Share
E-mailGet Alerts ABUS Hot Sheet
Price: $3.07 -4.06%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 13 | New: 41
Trade Now!
Join SI Premium – FREE
JMP Securities analyst Liisa Bayko lowered the price target on Arbutus Biopharma (NASDAQ: ABUS) to $7.00 (from $8.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- BlueScope Steel Limited (BSL:AU) (BLSFY) PT Raised to AUD22.50 at Credit Suisse
- Hoshizaki Corp. (6465:JP) PT Raised to JPY8,200 at Morgan Stanley
- Mineral Resources Limited (MIN:AU) (MALRF) PT Lowered to AUD32 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
